Novel intracellular delivery system of antisense oligonucleotide by self-assembled hybrid micelles composed of DNA/PEG conjugate and cationic fusogenic peptide

Bioconjugate Chemistry

Volumn 14, Issue 2, 2003, Pages 473-479

  Jeong, Ji Hoon ^a   Kim, Sung Wan ^b   Park, Tae Gwan ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICELLES; OLIGONUCLEOTIDES; PEPTIDES; POLYELECTROLYTES; POLYETHYLENE OXIDES; SOLUTIONS;

ACIDIC CONDITIONS; ANTISENSE OLIGONUCLEOTIDES; CATIONICS; COMPLEX MICELLES; DELIVERY SYSTEMS; DIBLOCK-COPOLYMER; HYBRID MICELLE; INTRACELLULAR DELIVERY; PHOSPHORAMIDATES; POLYELECTROLYTE COMPLEXES;

POLYETHYLENE GLYCOLS;

ACID; ANION; ANTISENSE OLIGONUCLEOTIDE; CATION; COPOLYMER; DNA; ELECTROLYTE; HYBRID PROTEIN; LYSYLALANYLLLEUCYLALANINE; MACROGOL; PEPTIDE; PHOSPHORUS DERIVATIVE; PROTEIN C MYB; UNCLASSIFIED DRUG;

ACIDITY; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CELL TRANSPORT; COMPLEX FORMATION; CONJUGATION; CONTROLLED STUDY; COVALENT BOND; DEGRADATION; DRUG DELIVERY SYSTEM; DRUG STRUCTURE; DRUG TRANSPORT; ENDOSOME; HYBRID; HYDRODYNAMICS; MICELLE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PARTICLE SIZE; SMOOTH MUSCLE FIBER;

ANIMALIA;

EID: 0037344136     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc025632k     Document Type: Article

References (37)

1. Stein, C. A., and Cheng, Y. C. (1993) Antisense oligonucleotides as therapeutic agents - is the bullet really magical? Science 261, 1004-12.
2. Crooke, S. T. (1993) Progress toward oligonucleotide therapeutics: Pharmacodynamic properties. FASEB J. 7, 533-539.
3. Gewirtz, A. M., Sokol, D. L., and Ratajczak, M. Z. (1998) Nucleic acid therapeutics: State of the art and future prospects. Blood 92, 712-736.
4. Bennett, C. F. (1998) Antisense oligonucleotides: Is the glass half full or half empty? Biochem. Pharmacol. 55, 9-19.
5. Calabretta, B., Skorski, T., Ratajczak, M. Z., and Gewirtz, A. M. (1996) antisense strategies in the treatment of leukemias. Semin Oncol 23, 78-87.
6. Skorski, T., Nieborowska-Skorska, M., Wlodarski, P., Zon, G., Iozzo, R. V., and Calabretta B. (1996) antisense oligodeoxynucleotide combination therapy of primary chronic myelogenous leukemia blast crisis in SCID mice. Blood 88, 1005-1012.
7. Bennett, M. R., Anglin, S., McEwan, J. R., Jagoe, R., Newby, A. C., and Evan, G. I. (1994) Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides. J. Clin. Invest. 93, 820-828.
8. Simons, M., Edelman, E. R., DeKeyser, J. L., Langer, R., and Rogenberg, R. D. (1992) antisense c-myc oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature 359, 67-70.
9. Wagner, R. W. (1994) Gene inhibition using antisense oligodeoxynucleotides. Nature 372, 333-335.
10. Jeong, J. H., and Park, T. G., (2001) Novel polymer-DNA hybrid polymeric micelles composed of hydrophobic poly(D,Llactic-co-glycolic acid) and hydrophilic oligonucleotides. Bioconjugate Chem. 12, 917-923.
11. Agrawal, S., Goodchild, J., Civeira, M. P., Thornton, A. H., Sarin, P. S., and Zamecnik, P. C. (1988) Oligodeoxy-nucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus. Proc. Natl. Acad. Sci. U.S.A. 85, 7079-83.
12. Egholm, M., Buchardt, O., Christensen, L., Behrens, C., Frier, S. M., Driver, D. A., Berg, R. H., Kim, S. K, Norde'n, B., and Nielsen, P. E. (1993) PNA hybridizes to complementary oligo-nucleotides obeying the Watson-Crick hydrogen bonding rules. Nature (London) 365, 566-568.
13. Pagnan, G., Stuart, D. D., Pastorino, F., Raffaghello, L., Montaldo, P. G., Allen, T. M., Calabretta, B., and Ponzoni, M. (2000) Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD 2 -targeted immunoliposomes: antitumor effects. J. Natl. Cancer Inst. 92, 253-61.
14. Juliano, R. L., and Akhtar, S. (1992) Liposomes as a drug delivery system for antisense oligonucleotides antisense Res. Dev. 2, 165-76.
15. Meyer, O., Kirpotin, D., Hong, K., Sternberg, B., Park, J. W., Woodlei, M. C., and Papahadjopoulos, D. (1998) Cationic liposomes coated with poly(ethylene glycol) as carriers for oligonucleotides. J. Biol. Chem. 25, 15621-15627.
16. Kim, J. S., Kim, B.-I., Maruyama, A., Akaike, T., and Kim, S. W. (1998) A new nonviral DNA delivery vector: the terplex system. J. Controlled Release 53, 175-182.
17. Katayose, S., and Kataoka, K. (1997) Water-soluble polyion complex associates of DNA and poly(ethyeneglycol)-poly(Llysine) block copolymer. Bioconjugate Chem. 8, 702-707.
18. Katayose, S., and Kataoka, K. (1998) Remarkable increase in nuclease resistance of plasmid DNA through supramolecular assembly with poly(ethyeneglycol)-poly(L-lysine) block copolymer. J. Pharm. Sci. 87, 160-163.
19. Harada, A., Togawa, H., and Kataoka, K. (2001) Physicochemical properties and nuclease resistance of antisenseoligonucleotides entrapped in the core of polyion complex micelles composed of poly(ethyeneglycol)-poly(L-lysine) block copolymer. Eur. J. Pharm. Sci. 13, 35-42.
20. Kataoka, K., Togawa, H., Harada, A., Yasugi, K., Matsumoto, T., and Katoyose, S. (1996) Spontaneous formation of polyion complex micelles with narrow distribution from antisense oligonucleotide and cationic block copolymer in physiological saline. Macromolecules 29, 8556-8557.
21. Vinogradof, S., Batrakova, E., Li, S., and Kabanov, A. (1999) Polyion complex micelles with protein-modified corona for receptor-mediated delivery of oligonucleotides into cells. Bioconjugate Chem. 10, 851-860.
22. Choi, Y. H., Liu, F., Choi, J. S., Kim, S. W., and Park, J. S. (1999) Characterization of a targeted gene carrier, lactosepoly(ethylene glycol)-grafted poly-L-lysine, and its complex with plasmid DNA. Hum. Gene Ther. 10, 2657-2665.
23. Lee, H., Jeong, J. H., and Park, T. G. (2002) PEG grafted polylysine with fusogenic peptide for gene delivery: high transfection efficiency with low cytotoxicity, J. Controlled Release 79, 283-291.
24. Lee, H., Jeong, J. H., and Park, T. G. A New Gene Delivery Formulation of polyethyleneimine/DNA complexes coated with PEG conjugated fusogenic peptide, J. Controlled Release 76, 138-192.
25. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay, J. Immunol. Methods 65, 55-63.
26. Leonardi, A., DeFranchis, G., Fregona, I. A., Violato, D., Plebani, M., and Secchi, A. G. (2001) Effects of Cyclosporin A on Human Conjunctival Fibroblasts. Arch. Ophthalmol. 119, 1512-1517.
27. Stewart, D. A., Thomas, S. D., Mayfield, C. A., and Miller, D. M. (2001) Psoralen-modified clamp-forming antisense oligonuleotides reduce cellular c-Myc protein expression and B16-F0 proliferation. Nucleic Acid Res. 19, 4052-4061.
28. Chu, B. C. F., Wahl, G. M., and Orgel, L. E. (1983) Derivatization of unprotected polynucleotides. Nucleic Acid Res. 11, 6513-6529.
29. Rahil, J., and Haake, P. (1981) Reactivity and mechanism of hydrolysis of phoshonamides. J. Am. Chem. Soc. 103, 1723-1734.
30. de Vrueh, R. L. A., Rump, E. T., Sliedregt, L. A. J. M., Biessen, E. A. L., van Berkel, T. J. C., and Bijsterbosch, M. K. (1999) Synthesis of a lipophilic prodrug of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and its incorporation into a hepatocyte-specific lipidic carrier. Pharm. Res. 16, 1179-1185.
31. Wyman, T. B., Nicol, F., Zephalti, O., Scaria, P. V., Plank, C., and Szoka, F. C. (1997) Design, Synthesis, and Characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers, Biochemistry 36, 3008-3017.
32. Lim, D. W., Yeom, Y. I., and Park, T. G. (2000) Poly(DMAEMA-NVP)-b-PEG-galactose as Gene Delivery Vector for Hepatocytes. Bioconjugate Chem. 11, 688-695.
33. Liaw, J., Aoyagi, T., Kataoka, K., Sakurai, Y., and Okano, T. (1999) Permeation of PEO-PBLA-FITC polymeric micelles in aortic endothelial cells. Pham. Res. 16, 213-220.
34. Ross, R. (1986) The pathogenesis of atherosclerosis-an update. N. Engl. J. Med. 314, 488-500.
35. Simons, M., Edelman, E. R., DeKeyser, J. L., Langer, R., and Rogenberg, R. D. (1992) antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature 359, 67-70.
36. Villa, A. E., Guzman, L. A., Poptic, E. J., Labhasetwar, V., D'Souza, S., Farrell, C. L., Plow, E. F., Levy, R. J., DiCorleto, P. E., and Topol. E. J. (1995) Effect of antisense c-myb oligonucleotides on vascular smooth muscle cell proliferation and response to vessel wall injury. Circ. Res. 76, 505-513.
37. Biro, S, Fu, Y.-M, Yu, Z.-X, and Epstein, S. E. (1993) Inhibitory effects of antisense oligodeoxynucleotide targeting c-myc mRNA on smooth muscle cell proliferation and migration. Proc. Natl. Acad. Sci. U.S.A. 90, 654-658.